EUVIMEDEUVIMED entdecken
Crossref

In vitro study on the effect of fibrinogen γ-chain peptide-coated ADP-encapsulated liposomes on postcardiopulmonary bypass coagulopathy using patient blood

Osamu Ishida, Kohsuke Hagisawa, Nozomu Yamanaka, Hiroyuki Nakashima, Bradley M Kearney, Koji Tsutsumi, Shinji Takeoka, Manabu Kinoshita

Journal of Thrombosis and Haemostasis · 2023

DOI: 10.1016/j.jtha.2023.03.018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2023. Verfasst von Osamu Ishida und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, National Defense Medical College, Tokorozawa, Japan. Electronic address: oishida2000@gmail.com. Hauptthemen laut MEDLINE: Liposomes, Blood Coagulation Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Fibrinogen γ-chain peptide-coated, adenosine 5'-diphosphate (ADP)-encapsulated liposomes (H12-ADP-liposomes) are potent hemostatic adjuvants that promote platelet thrombi formation at bleeding sites. Although we have reported the efficacy of these liposomes in a rabbit model of cardiopulmonary bypass coagulopathy, we are yet to address the possibility of their hypercoagulative potential, especially in human beings. OBJECTIVES: Considering its future clinical applications, we herein investigated the safety of using H12-ADP-liposomes in vitro using blood samples from patients who had received platelet transfusion after cardiopulmonary bypass surgeries. METHODS: Ten patients receiving platelet transfusions after cardiopulmonary bypass surgery were enrolled. Blood samples were collected at the following 3 points: at the time of incision, at the end of the cardiopulmonary bypass, and immediately after platelet transfusion. After incubating the samples with H12-ADP-liposomes or phosphate-buffered saline (PBS, as a control), blood coagulation, platelet activation, and platelet-leukocyte aggregate formation were evaluated. RESULTS: Patients' blood incubated with H12-ADP-liposomes did not differ from that incubated with PBS in coagulation ability, degree of platelet activation, and platelet-leukocyte aggregation at any of the time points. CONCLUSION: H12-ADP-liposomes did not cause abnormal coagulation, platelet activation, or platelet-leukocyte aggregation in the blood of patients who received platelet transfusion after a cardiopulmonary bypass. These results suggest that H12-ADP-liposomes could likely be safely used in these patients, providing hemostasis at the bleeding sites without causing considerable adverse reactions. Future studies are needed to ensure robust safety in human beings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiposomesBlood Coagulation DisordersAnimalsHumansRabbitsAdenosine DiphosphateFibrinogenBlood PlateletsHemorrhagePlatelet AggregationPeptidesCardiopulmonary Bypass

Stichwörter der Autor:innen

blood substitutescardiopulmonary bypasscoagulopathyplatelet

Substanzen

LiposomesAdenosine DiphosphateFibrinogenPeptides

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, National Defense Medical College, Tokorozawa, Japan. Electronic address: oishida2000@gmail.com.
  • Department of Physiology, National Defense Medical College, Tokorozawa, Japan.
  • Department of Cardiovascular Surgery, National Defense Medical College, Tokorozawa, Japan.
  • Department of Immunology and Microbiology, National Defense Medical College, Tokorozawa, Japan.
  • Research Institute for Science and Engineering, Waseda University, Tokyo, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Ishida, O., Hagisawa, K., Yamanaka, N., Nakashima, H., Kearney, B. M., Tsutsumi, K., Takeoka, S., & Kinoshita, M. (2023). In vitro study on the effect of fibrinogen γ-chain peptide-coated ADP-encapsulated liposomes on postcardiopulmonary bypass coagulopathy using patient blood. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2023.03.018

Vancouver

Ishida O, Hagisawa K, Yamanaka N, Nakashima H, Kearney BM, Tsutsumi K, et al. In vitro study on the effect of fibrinogen γ-chain peptide-coated ADP-encapsulated liposomes on postcardiopulmonary bypass coagulopathy using patient blood. Journal of Thrombosis and Haemostasis. 2023. doi:10.1016/j.jtha.2023.03.018

BibTeX
@article{Ishida2023,
  author = {Ishida, Osamu and Hagisawa, Kohsuke and Yamanaka, Nozomu and Nakashima, Hiroyuki and Kearney, Bradley M and Tsutsumi, Koji and Takeoka, Shinji and Kinoshita, Manabu},
  title = {In vitro study on the effect of fibrinogen γ-chain peptide-coated ADP-encapsulated liposomes on postcardiopulmonary bypass coagulopathy using patient blood},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2023},
  doi = {10.1016/j.jtha.2023.03.018}
}
Kostenlos starten →